Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Folate Supplement Cuts Risk of Placental Abruption
Link ID 5438
Title Folate Supplement Cuts Risk of Placental Abruption
Url http://www.medscape.com/viewarticle/573887?src=rss
Description Use of folic acid and other vitamin supplements before or during pregnancy appears to reduce the risk of placental abruption, Norwegian researchers report in the April issue of the American Journal of Epidemiology. Reuters Health Information
Category Articles > Obstetrics and Gynecology
Keywords
Date May 3, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Obstetrics and Gynecology
1. Megestrol Acetate Reduces Hot Flashes in Women With Breast Cancer
  A 20-mg daily dose of the progestin megestrol acetate significantly reduces vasomotor symptoms in women with breast cancer, according to the results of a multicenter, phase III, double-blind, trial published in the April 1st issue of the Journal of Clinical Oncology. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


2. Pregnancy May Be Risky for Some Women With Hereditary Telangiectasia
  Although most pregnancies in women with hereditary hemorrhagic telangiectasia (HHT) proceed normally, a number of factors indicate that such women should be considered as being at high risk, according to UK and French researchers. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


3. Chronic Inflammation Not Seen Important in Development of Ovarian Cancer
  Results of a study published in the January issue of the International Journal of Cancer suggest that most factors that could cause ovarian inflammation are not associated with a significantly increased risk of ovarian cancer. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


4. HER-2 Improves Survival in Patients With Breast Cancer Brain Metastasis
  HER-2 status is a strong predictor of survival in patients with brain metastases from breast cancer, according to Boston-based researchers. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology


5. Many DCIS Patients Overestimate Recurrence Risk
  Although the risk of recurrence after treatment for ductal carcinoma in situ (DCIS) is very small, most patients believe that their risk is at least moderate, according to a report in the Journal of the National Cancer Institute for February 20th. Reuters Health Information
Category:   Articles > Obstetrics and Gynecology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS